Clinical significance and predictive risk factors for event-free survival at 24 months in patients with PTCL, NOS.

Cao, Zheng; Wang, Xiaojun; Xue, Xuemin; Feng, Xiaoli

Cao, Zheng; Wang, Xiaojun; Xue, Xuemin; Feng, Xiaoli.

Afiliação

Cao Z; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang X; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xue X; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Feng X; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. fengxl@hotmail.com.

Ann Hematol ; 103(3): 869-883, 2024 Mar.

Article em En | MEDLINE | ID: mdl-38040859

Assuntos

Linfoma de Células T Periférico; Humanos; Linfoma de Células T Periférico/diagnóstico; Linfoma de Células T Periférico/terapia; Linfoma de Células T Periférico/patologia; Intervalo Livre de Progressão; Estudos Retrospectivos; Relevância Clínica; Prognóstico; Fatores de Risco

Palavras-chave

Event-free survival at 24 months; Peripheral T Cell lymphoma, not otherwise specified; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google